학술논문
Effect of Tabernero's prognostic subgroups or development of neutropenia on survival outcomes of patients with refractory metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil plus bevacizumab (TASBEV) in real-world practice.
Document Type
Article
Author
Source
Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p99-99, 1p
Subject
Language
ISSN
0732183X